Bright Distribution, the pharmaceutical wholesale business will be strategically positioned to capitalize on opportunities in the market with special emphasis on third and fourth generation cardiovascular products and other difficult to source pharmaceutical products in short supply. The wholesale business will utilize a new business model for sourcing such products. The model entails acquiring intellectual property rights (IPR) for these products as opposed to the prevailing agency-principal model which is unsustainable. Medical equipment and medical disposables from unique suppliers will complement the pharmaceutical business.